MOUD Prescribing Authority and Practice Implications

MOUD Prescribing Authority and Practice Implications

SKU: CEI-MOUD-PRESCRI-1778385600-PODCAS-PH-10131
9.00 USD In stock Buy at Merchant

Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care. Upon successful completion of this course, pharmacists should be able to: 1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder. 2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice. Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls Korey Kreider, PharmD Pharmacist Owner Medicine Man Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose. Course fee includes course materials and CPE credit submission to CPE Monitor. Course is non-refundable. Release Date: 5/11/2026 Planned Expiration Date: 5/11/2027 Recording, capturing, or sharing any part of this presentation is strictly prohibited. This includes the use of AI note-taking tools, audio/video devices, or screen capture technology. Please help us protect the privacy of our speakers and the integrity of the educational content. Copyright 2026, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden. Universal Activity Number (UAN): 0107-0000-26-150-H01-P Application-based CPE Activity Release Date: May 9, 2026 Planned Expiration Date: May 10, 2027 CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net. ¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Specifications
Duration
1h
CEUs
0.1
Target Role
Pharmacist

AI Readiness

Good foundation, but some important product data is still missing.

75%